Pharmaceutical Qib HFA-134a,Kuj dav hu ua Norflurane (1,1,1,2-Tetrafluoroethane), yog lub ntiaj teb kub-tus qauv hydrofluoroalkane propellant tshwj xeeb tsim rau kev tsim tshuaj aerosol, pressurized metered-dose inhalers (pMDIs), kev xa tshuaj ua pa, tshuaj tsuag qhov ntswg thiab tshuaj pleev ib ce.
Tsis zoo li kev lag luam -qib R134a tub yees siv rau HVAC thiab cov tshuab ua kom txias, tshuaj- qib HFA134a tau dhau ntau-theem rectification, noo noo tshem tawm, kua qaub purification thiab hnyav hlau pom kom tau raws li USP nruj-NF, European Pharmacopia (J) Pharmacopia (Japanese Pharmacopia) kev xav tau. Nws yog CFC-dawb, ozone- nyab xeeb, tsis yog -flammable thiab low-toxicity propellant uas hloov tag nrho cov tshuaj ozone{11}} depleting CFC propellants txwv nyob rau hauv Montreal Protocol.
Rau cov chaw tsim tshuaj, cov chaw sim tshuaj thiab cov chaw tsim tshuaj aerosol OEM, siab -purity HFA-134a lav zoo ib yam aerosol particle loj, ruaj khov ncua kev siv tshuaj, meej metered dosing thiab ntev formulation txee lub neej - cov cim tseem ceeb rau kev tsim nyog cov tshuaj ua pa.
1. Vim li cas Pharmaceutical Grade HFA 134a tseem yog kub -Txoj kev pMDI Propellant hauv 2026
Txawm hais tias tsis tshua muaj -GWP lwm cov tshuaj tiv thaiv xws li HFO-1234ze thiab HFA 152a tau tshwm sim nyob rau hauv xyoo tas los no, HFA-134a tseem yog qhov kev pom zoo tshaj plaws, tshuaj xyuas thiab kev tsim cov tshuaj tiv thaiv rau kev tsim tshuaj aerosol thoob ntiaj teb. Rau B2B cov kws yuav khoom thiab cov kws tsim qauv tsim qauv, HFA-134a muab cov txiaj ntsig tsis tuaj yeem hloov pauv hauv kev nyab xeeb, sib xws thiab kev ua raws cai.
1.1 Superior Drug Delivery & Formulation Stability
High-purity HFA-134a xa cov vapor siab ruaj khov thiab kev ua haujlwm tsis zoo ntawm atomization raws li tus qauv tsim thiab khaws cia kub (15-30℃). Nws tswj hwm kev ncua kev sib koom ua ke rau cov tshuaj steroid, bronchodilators thiab cov qauv sib xyaw ua ke, kom ntseeg tau tias muaj qhov zoo sib xws (FPF) thiab txhim khu kev qha tob tob rau kev kho mob ua pa. Tsis zoo li qhov qis-GWP lwm txoj hauv kev uas yuav tsum tau hloov kho cov qauv, HFA134a tau ua tiav nrog cov pMDI uas twb muaj lawm paub tab thiab cov qauv tshuaj.
1.2 Txoj Cai Tswjfwm Ntiaj Teb Tag Nrho
Peb cov kws tshuaj HFA 134a yog FDA DMF lees paub, USP / EP / JP ua raws, REACH sau npe thiab Montreal Protocol tau lees paub. Nws txhawb kev sau npe ntawm cov chaw muag tshuaj, GMP Rhiav kev tshawb xyuas thiab daim ntawv sau npe tshuaj thoob ntiaj teb, pab cov tuam txhab lag luam kom tsis txhob ua raws li kev tsis lees paub thiab kev cuam tshuam kev lag luam.
1.3 Zero ODP, Tsawg Toxicity; Tsis yog -Flammable Safety Profile
HFA 134a nta xoom ozone depletion muaj peev xwm, tsis yog - cov khoom tawg yooj yim thiab tsis tshua muaj mob toxicity. Nws muaj kev nyab xeeb rau tib neeg txoj kev ua pa thiab tsim nyog rau kev siv tshuaj kho mob ntev - lub sij hawm, yog vim li cas nws thiaj li tseem nyiam rau cov me nyuam inhalers, kev kho kab mob ua pa ntev thiab tshuaj aerosols hauv tsev txhua hnub.
Tiv tauj peb kom paub meej ntxiv
2. Core Applications of Bulk Pharmaceutical HFA 134a
B2B cov chaw muag tshuaj thiab cov tshuaj aerosol feem ntau siv peb lub siab -purity HFA134a hauv qab no siab - qauv kev kho mob:
Asthma & COPD pMDI InhalersAlbuterol, budesonide, glycopyrronium thiab kev kho ua pa ua ke
Nasal Pharmaceutical Sprays:Steroid nasal sprays, decongestant aerosols thiab anti- allergy nasal formulations
Tshuaj kho mob Aerosols: Cov tshuaj tua kab mob tua kab mob, tshuaj tua kab mob aerosols thiab tshuaj tua kab mob ntawm daim tawv nqaij
Emerging Needle-Kev xa tshuaj dawb: Pulmonary txhaj tshuaj tiv thaiv kab mob ntsws thiab cov khoom siv ntse IoT nqus pa
3. Technical Specifications ntawm hFA 134a propellant
Physicochemical Properties
| Khoom | Specification |
|---|---|
| Tshuaj npe | 1,1,1,2-Tetrafluoroethane |
| Molecular Formula | CF₃CH₂F |
| Molecular Luj | 102.03 g / mol |
| Boiling Point | -26.3 ° F (-15.3 ° F) |
| Vapor Siab | 5.7 bar ntawm 20 degree |
| Ceev (kua, 25 degree) | 1.21 g / cm³ |
| Ozone Depletion Potential (ODP) | 0 |
| Ntiaj Teb Warming Potential (GWP) | 1430 |
Purity Specifications
Cov yam ntxwv ua haujlwm
Particle loj faib: 1-5 μm (zoo tagnrho rau pulmonary tus me nyuam)
Dose uniformity: Tsawg dua los yog sib npaug li 5% variation ntawm actuations
Kub stability: 15-30℃kev khiav hauj lwm ntau yam
4. Peb Tswj HFA-134a Purity li cas rau GMP Pharmaceutical Production
Raws li ib tug kws tshaj lij HFA134a tus neeg muag khoom pabcuam thoob ntiaj teb cov chaw tsim tshuaj, peb siv tag nrho -chain tswj kom ntseeg tau tias txhua pawg ua tau raws li cov tshuaj pharmacopoeia- cov qauv qib:
Multi-stage rectification purification: Tshem tawm cov residues hnyav, organic impurities thiab ya raws kom ntseeg tau 99.99% ultra- siab purity
Batch-los ntawm-batch tag nrho kev ntsuas ntsuas: Muab daim ntawv pov thawj COA batch tiav, spectrum txheeb xyuas daim ntawv qhia thiab tsom xam impurity
Kev thauj mus los: Ua raws li IATA & IMDG cov qauv khoom txaus ntshai rau kev xa khoom thoob ntiaj teb
5.Kev sib piv nrog lwm yam Propellants
| Parameter | HWV 134a | HWV 152a | HFA 227 ua | HFO-1234 ua |
|---|---|---|---|---|
| ODP | 0 | 0 | 0 | 0 |
| GWP | 1430 | 138 | 3220 | <1 |
| Kub Point (degree) | -26.3 | -24.7 | -16.4 | -19 |
| Vapor Siab (bar, 20 degree) | 5.7 | 4.16 | 3.9 | 4.2 |
6. Cov neeg yuav khoom FAQ|B2B Pharmaceutical HFA134a Sourcing Questions
Peb txheeb tawm cov lus nug uas nquag nug los ntawm cov neeg muag tshuaj thoob ntiaj teb, cov kws tsim qauv tsim thiab pab pawg kuaj xyuas zoo:
Q1: Puas yog koj HFA134a ua raws li USP, EP thiab FDA cov cai?
A1: Yog. Peb cov kws tshuaj -qib HFA134a nruj me ntsis raws li USP-NF, European Pharmacopoeia thiab Japanese Pharmacopoeia cov qauv, nrog FDA DMF lees paub thiab tag nrho REACH rau npe rau kev nkag mus rau thoob ntiaj teb kev lag luam tshuaj.
Q2: Cov kev xaiv ntim khoom ntim dab tsi koj muab?
A2: Cov txheej txheem kev lag luam steel lub tog raj kheej ntim, customized bulk ton ntim thiab ntev -lub sij hawm OEM muab kev daws teeb meem rau cov chaw muag tshuaj loj.
Q3: Koj puas tuaj yeem muab cov ntaub ntawv pov thawj COA, SDS thiab pharmacopoeia?
A3: Yog. Peb muab COA batch pub dawb, daim ntawv pov thawj kev nyab xeeb (SDS), cov ntawv ceeb toom tsis huv thiab cov ntaub ntawv tsim nyog rau kev kuaj xyuas lub Hoobkas thiab cov khoom sau npe.
Q4: Puas yog koj HFA134a haum rau cov menyuam yaus nqus pa thiab cov tshuaj rhiab heev?
A4: Yog lawm. Ultra-tsawg impurity, pes tsawg acid cov ntsiab lus thiab ruaj khov atomization kev ua tau zoo ua rau nws tag nrho tsim nyog rau siab -tus qauv me nyuam txoj kev siv tshuaj ua pa.
Peb txoj kev cog lus rau Kev Ua Zoo & Sustainability
Raws li tus neeg muab kev ntseeg siab ntawm Norflurane HFA 134a, peb xyuas kom meej:
✔ Siab -Purity Pharmaceutical Qib(ua tau raws li cov qauv tshuaj pharmacopeia thoob ntiaj teb)
✔ Kev Tswj Xyuas Zoo(Batch kuaj rau impurities, noo noo, thiab stability)
✔ Sustainable Sourcing & Logistics(tsawg kawg carbon footprint)
✔ Kev them nyiaj yug rau Aerosol Manufacturers(formulation optimization, tswj kev taw qhia)
Koom tes nrog Trusted HFA 134a Propellant Supplier
Norflurane HFA 134a tseem yog qhov kev ntseeg siab tshaj plaws rau cov tshuaj aerosol hauv tsev muag tshuaj, muab kev ua haujlwm tsis sib xws hauv cov tshuaj aerosols thiab aerosol kev lag luam hauv tsev muag tshuaj.
Raws li cov kev cai hloov zuj zus mus thiab tom ntej no - tiam propellants tshwm sim, peb txuas ntxiv muab siab - zoo HFA 134a thaum txhawb kev tsim kho tshiab hauv aerosol pharma.
Tiv tauj peb hnub no los tham txog koj cov tshuaj aerosol propellant xav tau thiab xyuas kom koj cov formulations ua tau raws li cov qauv kev lag luam siab tshaj plaws.
Peb qhov chaw nyob
Room 1102, Unit C, Xinjing Center, No.25 Jiahe Road, Siming District, Xiamen, Fujian, Suav teb
Xov tooj
+86-592-5803997
E -mail
susan@xmjuda.com
